Andrew Stewart, M.D.
Director, Diabetes, Obesity and Metabolism Institute; Professor of Medicine
Mount Sinai School of Medicine
Medicine - Division of Endocrinology
Mount Sinai School of Medicine, Atran 4-5, Room 402, One Gustave L. Levy Place, Box 1152
New York, NY 10029
Andrew Stewart, M.D. - Investigator Profile
Andrew Fyfe Stewart, M.D.
Irene and Arthur M. Fishberg Professor, Mount Sinai School of Medicine, New York, NY.
Director, Diabetes, Metabolism and Obesity Institute, Mount Sinai School of Medicine, NY, NY
Dr. Andrew Stewart has led a career devoted to patient care and basic and clinical research in endocrinology and diabetes research for over 30 years. He served as the Chief, Division of Endocrinology and Metabolism at the University of Pittsburgh School of Medicine from 1997 to 2012. He also served as the Co-Director of the University of Pittsburgh Diabetes Institute. He assumed his current positions at Mount Sinai in November 2012.
Dr. Stewart''s research focuses on three areas. The first is the regulation of calcium and bone metabolism. He and his group discovered parathyroid hormone-related protein (PTHrP), a new hormone that is currently showing promise as a pure anabolic skeletal agent for the treatment of osteoporosis. He also has an interest in vascular cell biology and arterial re-stenosis following angioplasty and coronary stenting. Finally, he currently is spending most of his time understanding and developing novel means for inducing the replication and regeneration of pancreatic beta cells. His lab was the first to demonstrate that growth factors could drive beta cell replication, and also improve glucose control in living animals. He was also the first to carefully define cell cycle control in the rodent and human beta cell, and is actively involved in understanding why beta cells normally do not replicate, and how they can be induced to replicate. This work is the subject of invited symposia at both the American Diabetes Association (ADA), the European Islet Study Group (ISG), and the European Association for the Study of Diabetes (EASD).
Dr. Stewart received his bachelor''s degree from Trinity College in Hartford, Connecticut and his M.D. from Columbia University, College of Physicians and Surgeons, New York, New York. He served as a fellow in Endocrinology and Metabolism at Yale University School of Medicine in Connecticut.
Prior to moving to the University of Pittsburgh in 1997, Dr. Stewart was tenured professor at Yale University School of Medicine, where he served for the preceding 19 years. He has received numerous honors, including Councilor of both the Endocrine Society as well as the American Society for Bone and Mineral Research (ASBMR); Secretary-Treasurer of the Endocrine Society, and Chair of the Research Policy Committee for the ADA. He has given numerous lectureships and invited symposia at Johns Hopkins, the University of Pennsylvania, the National Institutes of Health, Yale University, Massachusetts General Hospital, UC San Francisco, and many others, as well as at the Annual Meetings of the Endocrine Society, the American Diabetes Association, and the American Society for Bone and Mineral Research. In addition, he is regularly recognized as one of the Best Doctors in America. He has published 230 scientific papers, with many in journals of the highest quality, including the Proceedings of the National Academy of Sciences, the New England Journal of Medicine, and Science. Dr. Stewart is the continuous recipient of numerous research grants for the past 30 years. He currently has strong support from the NIH, and the American Diabetes Association, the JRDF and other agencies. He was the 2008 recipient of the Endocrine Society''s Gerald Aurbach Award for outstanding scientific achievement. He was the Scientific Sessions Committee Chair for the American Diabetes Association Annnual Meetings in 2010 and 2011.
Cell Cycle Control
Human Beta Cells